Market revenue in 2023 | USD 8.0 million |
Market revenue in 2030 | USD 15.7 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.75% in 2023. Horizon Databook has segmented the Sweden pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden holds a strong position in drug development and discovery from phase I to phase III trials. The country's growing number of clinical trials is driving the market growth. Sweden's life sciences industry is very strategic, focusing on world-class innovation and excellent R&D.
This can be observed through the significant increase in start-ups and academic spinouts focusing on life sciences in the previous 15 years. With a solid basis in life sciences, especially in pharmaceutical R&D, the life sciences industry is Sweden's second-largest export industry.
This newly approved aseptic filling line marks a substantial expansion of manufacturing capabilities at Sever Pharma Solutions' Malmo site. Notably, this expansion enables seamless integration with the company's assembly solutions for auto-injectors.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Sweden pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account